Q3 Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Q3 Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.68M	Buy	+52,918	New	+$7.15M	1.22%	11
2026 Q1	–	Sell	-47,249	Closed	-$5.76M	–	91
2025 Q4	$5.76M	Buy	+47,249	New	+$5.42M	1.32%	13
2020 Q1	–	Sell	-39,881	Closed	-$3.79M	–	42
2019 Q4	$3.79M	Buy	+39,881	New	+$3.45M	8.54%	5
2019 Q2	–	Sell	-36,283	Closed	-$3.29M	–	43
2019 Q1	$3.29M	Buy	+36,283	New	+$3.09M	8.85%	3
2018 Q3	–	Sell	-61,243	Closed	-$5.83M	–	38
2018 Q2	$5.83M	Sell	61,243 -662	-1%	-$60.8K	6.4%	5
2018 Q1	$5.43M	Buy	+61,905	New	+$5.65M	6.14%	6

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Q3 Asset Management's XBI Position: Q2 2026 in Review

Q3 Asset Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 52,918 shares worth $6.68M. The stake represents 1.22% of the portfolio and ranks #11 among its holdings. This is a return to the name: Q3 Asset Management previously reported a position in XBI as recently as Q4 2025.

Q3 Asset Management first reported a position in XBI in Q1 2018 and has held it in 6 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Q3 Asset Management held 52,918 shares of State Street SPDR S&P Biotech ETF worth $6.68M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Q3 Asset Management position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 1.22% of Q3 Asset Management's portfolio in Q2 2026, its #11 holding.
Q3 Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 6 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Q3 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.